Matches in Wikidata for { <http://www.wikidata.org/entity/Q91902409> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q91902409 description "artículu científicu espublizáu en febreru de 2020" @default.
- Q91902409 description "im Februar 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91902409 description "scientific article published on 07 February 2020" @default.
- Q91902409 description "wetenschappelijk artikel" @default.
- Q91902409 description "наукова стаття, опублікована 7 лютого 2020" @default.
- Q91902409 name "Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial" @default.
- Q91902409 name "Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial" @default.
- Q91902409 type Item @default.
- Q91902409 label "Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial" @default.
- Q91902409 label "Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial" @default.
- Q91902409 prefLabel "Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial" @default.
- Q91902409 prefLabel "Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial" @default.
- Q91902409 P1433 Q91902409-DAC2D7A0-2333-4F8F-93C4-910DC9CF75F0 @default.
- Q91902409 P1476 Q91902409-B778A21A-A915-42E4-A466-4ED7AEA1BE4C @default.
- Q91902409 P2093 Q91902409-083B8DE4-0362-4BAE-9B63-B64C2D00F5D7 @default.
- Q91902409 P2093 Q91902409-1DC554E8-E8AA-4812-A4F0-C602DB5DE3E0 @default.
- Q91902409 P2093 Q91902409-4C78C8D2-66C3-42AD-A372-5930BFE54510 @default.
- Q91902409 P2093 Q91902409-B41ABFD2-05C6-46E1-B0EC-C0C75B35D063 @default.
- Q91902409 P2093 Q91902409-CBFF5AE3-77A6-4866-B26E-8BB4E8ED462B @default.
- Q91902409 P2093 Q91902409-DAB8F204-B895-4919-8E8E-8E50C9F799D3 @default.
- Q91902409 P2093 Q91902409-E2E7E7C9-7AD1-4307-95D7-C631A9A43728 @default.
- Q91902409 P2093 Q91902409-F27BD667-AF4E-4F18-B56D-E4A6583457AF @default.
- Q91902409 P304 Q91902409-8E63631D-4BA2-47A1-A8CD-71BAEE326E71 @default.
- Q91902409 P31 Q91902409-9BB5DDA5-5569-40BD-A0AF-345D8F8F4B54 @default.
- Q91902409 P356 Q91902409-9D512936-6F38-454D-896D-242F6A4C69FB @default.
- Q91902409 P433 Q91902409-3E29EC4E-A317-41E5-BCFE-9D1A8685335E @default.
- Q91902409 P478 Q91902409-EB8791B3-1759-4C38-B7B6-D007037ACBE7 @default.
- Q91902409 P50 Q91902409-2CF63144-A6CC-4708-A200-AB08B03B8967 @default.
- Q91902409 P50 Q91902409-36BC6B4D-5E64-4AD7-99AD-1ECF2D219516 @default.
- Q91902409 P50 Q91902409-EA693F72-B2A6-4505-B37F-317A265C4D3F @default.
- Q91902409 P577 Q91902409-ED3DDC9A-5C65-4D55-AA4A-C0CD06C48DEB @default.
- Q91902409 P698 Q91902409-E7F9E36F-1F1D-4446-ABE0-DEC8173BCF4D @default.
- Q91902409 P921 Q91902409-6A9522DC-54A8-4867-AF79-5335B4783F48 @default.
- Q91902409 P356 EIJ-D-18-01000 @default.
- Q91902409 P698 30803936 @default.
- Q91902409 P1433 Q26842537 @default.
- Q91902409 P1476 "Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial" @default.
- Q91902409 P2093 "Clemens von Birgelen" @default.
- Q91902409 P2093 "Eric Eeckhout" @default.
- Q91902409 P2093 "Evald Høj Christiansen" @default.
- Q91902409 P2093 "Hüseyin Ince" @default.
- Q91902409 P2093 "Michael Haude" @default.
- Q91902409 P2093 "Pedro Alves Lemos" @default.
- Q91902409 P2093 "Ralph Toelg" @default.
- Q91902409 P2093 "William Wijns" @default.
- Q91902409 P304 "e1375-e1382" @default.
- Q91902409 P31 Q13442814 @default.
- Q91902409 P356 "10.4244/EIJ-D-18-01000" @default.
- Q91902409 P433 "15" @default.
- Q91902409 P478 "15" @default.
- Q91902409 P50 Q1308604 @default.
- Q91902409 P50 Q7364511 @default.
- Q91902409 P50 Q92292516 @default.
- Q91902409 P577 "2020-02-07T00:00:00Z" @default.
- Q91902409 P698 "30803936" @default.
- Q91902409 P921 Q468414 @default.